Thromb Haemost 1967; 17(03/04): 418-422
DOI: 10.1055/s-0038-1654166
Originalarbeiten - Original Articles - Travaux Originaux
Schattauer GmbH

The Thrombolytic Effect of Heparin and a Heparin-Like Substance, SP 54

D. E. Fitz Gerald*
1   Department of Medicine, University of Pittsburgh and the Department of Medicine, Montefiore Hospital, Pittsburgh
,
Isabel L. F. Szeto
1   Department of Medicine, University of Pittsburgh and the Department of Medicine, Montefiore Hospital, Pittsburgh
,
Joel Spero
1   Department of Medicine, University of Pittsburgh and the Department of Medicine, Montefiore Hospital, Pittsburgh
,
Jessica H. Lewis
› Institutsangaben

Supported by research grants from the National Heart Institute, United States Public Health Service (HE 02254 and HE 03036) and a grant from the Pennsylvania Heart Association, and the Western Pennsylvania Heart Association, and the Anathan Research Fund.
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
26. Juni 2018 (online)

Preview

Summary

The intravenous administration of heparin or SP 54 produced statistically significant reductions in the weights of experimentally induced jugular thrombi, which had been allowed to grow for 48, 72, or 120 hrs before treatment. The results observed in the smaller saphenous veins were less striking.

* Current address: Department of Medicine, Guy’s Hospital Medical School, London Bridge, S. E. London.